Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

How many times have you tried to view a webpage, only to be barraged with pop-up windows, ads or email signup requests? If you’re anything like me, you get so frustrated that you close the window ...

Hair loss isn’t always dramatic. It can be incremental. You start noticing a bit more scalp in harsh bathroom lighting; a tiny bald spot when you tie your hair up in a ponytail. The shower drain is ...

The European Parliament has taken a rare and telling step: it has disabled built-in artificial intelligence features on work devices used by lawmakers and staff, citing unresolved concerns about data ...

OpenAI said in a filing that it won't launch its mysterious hardware product before February 2027. It also told a court it would not use the "io" name for any AI devices. OpenAI's first hardware ...

OpenAI's first Jony Ive-designed hardware device won't ship to customers until next year, new court filings show (via Wired). The motion stems from a trademark infringement lawsuit filed last year by ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the ...

The U.S. government quietly acquired a device in late 2024 that officials believe may be connected to the debilitating condition known as Havana Syndrome, which more than 1,500 American officials have ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.